A new perspective, published in npj Digital Medicine, has reviewed the status of digital clinical trials and described future priorities […]
Despite global recognition that diversity within population studies is poor, clinical trials for current treatments and vaccines for COVID-19 still […]
Availiable on demand here As we move towards an ever more personalised healthcare system, genomics is at the heart of […]
Ramon is head of RWE data and analytics. He works to turn the output of analytics models into business actions […]
“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]
Complex Innovative Design (CID) trials have the potential to increase efficiency and lower the costs of drug development. This type […]
Differences in genetics, physiology, race, ethnicity, age, and sex, as well as numerous other extrinsic factors, are known to affect […]
The cost of drug R&D has increased by ten-fold in the last 30 years, but the success rate of candidate […]
We recently interviewed Anandbir Brar, Chief Executive Officer of Excelra. Excelra is the lead sponsor for our D4 Global virtual event. […]
Health data is changing. Now, big data promises to breathe new life into clinical trial design. So, does this mean […]
